First published · Last updated
Specifically Editing Cancer Sialoglycans for Enhanced In Vivo Immunotherapy through Aptamer‐Enzyme Chimeras
A Wiley journal article describes editing cancer sialoglycans with aptamer–enzyme chimeras to enhance in vivo immunotherapy. The supplied excerpt contains only the publisher and content type and provides no additional details beyond the title.
Categories: science-and-space, public-health, positive-progress
Generated scores
Scores are based on the cited reporting and use a 1–10 scale. Read the methodology.
- Confidence
- 3/10
- Geographic reach
- 1/10
- Global importance
- 3/10
- Impact magnitude
- 3/10
- Positivity
- 6/10
- Urgency
- 2/10
Why it matters
The work aims to advance methods for enhancing in vivo cancer immunotherapy.

